Page 262 - ASHG 2013 Program Guide

POSTER SESSIONS
  249
POSTER SESSIONS
W=W
ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
esent
3326
F Inversion-mediated gene fusions involving
NAB2-STAT6
in malignant meningioma.
C. Ling, F. Gao,
L. Shi, G. Zada, W. J. Mack, K. Wang.
3327
W Copy number gains on chromosome 21
contribute to risk of acute lymphoblastic leukemia
in non-Down syndrome children.
A. J. de Smith, A.
M. Yiorkas, R. G. Walters, K. M. Walsh, C. Metayer,
L. F. Barcellos, P. A. Buffler, A. I. Blakemore, A. P.
Chokkalingam, J. L. Wiemels.
3328
T A case of hyperdiploidy in CLL/SLL: A rare
cytogenetic event associated with poor prognosis.
M.
DeNicola, S. Pullakat, S. Yea, P. Delgado, L. Yang, N. Rao,
C. A. Tirado.
3329
F The cytogenetic landscape and downstream
consequences in 16,172 cancer samples.
L. Franke, R.
S. N. Fehrmann, J. Karjalainen, L. de Vries, M. van Vugt,
C. Wijmenga.
3330
W Genomic copy number signatures uncovered
genetically distinct group which is different from
adenocarcinoma and squamous cell carcinoma of the
lung cancer.
E. Lee, J. Lee, H. Kim, B. Shin, J. Kim, A.
Kim, B. Kim.
3331
T The link between the losses of
TP53
and
ETV6
and del(5q) and/or -7/del(7q) in the progression
of myelodysplastic syndrome and acute myeloid
leukemia.
J. Lee, R. Zhang, Y. Kim, X. Wang, Y. Li, S. Li.
3332
F Targeted genomic DNA and cDNA next-
generation sequencing identifies a high f equency
of kinase gene fusions in Spitz tumors Involving
ROS1
,
ALK
,
RET
,
NTRK1
,
and
BRAF
.
K. Wang, J. He, T.
Wiesner, G. Otto, R. Yelensky, M. F. Berger, R. Esteve-
Puig, D. Lipson, K. Brennan, V. A. Miller, M. T. Cronin, B. C.
Bastian, P. J. Stephens.
3333
W A rare case of de novo AML with basophilic
differentiation and abnormal cytogenetics with
tetraploidy and structural abnormalities in a 50-year-
old male.
A. Yenamandra, F. C. Wheeler, D. Zalepa, A.
Gardner, M. Guanchez-Lopez, M. A. Thompson, J. Douds,
S. Mohan, A. Shaver.
3334
T Complex karyotype in a patient with AML-M1.
L.
Bobadilla-Morales, C. Ortega-de la Torre, H. J. Pimentel-
Gutiérrez, C. Barba-Barba, M. C. Almodóvar-Cuevas, G.
Serafín-Saucedo, G. Macías-Salcedo, M. E. Velázquez-
RiverA, A. Márquez-Mora, S. Gallegos-Castorena, F.
Sánchez-Zubieta, A. Corona-Rivera.
3335
F Single chromosome contribution to karyotypic
evolution in tumor formation and metastases.
J. Brown,
B. Flynn, C. Obergfell, M. Longo, M. O’Neill, R. O’Neill,
Peromyscus Genetic Stock Center.
3336
W The impact of microarray in diagnosing
pediatric acute lymphocytic leukemia.
C. M. Higgins, D.
L. Pickering, M. L. Wiggins, W. G. Sanger, B. J. Dave.
3315
W Association between colorectal cancer risk
and variants in the human exome.
T. A. Harrison, M.
Lemire, F. R. Schumacher, P. L. Auer, C. Qu, S. I. Berndt,
S. Bézieau, H. Brenner, P. T. Campbell, A. T. Chan, J.
Chang-Claude, D. V. Conti, D. Duggan, S. Gallinger, R. C.
Green, S. B. Gruber, E. Jacobs, S. Jiao, L. Le Marchand,
L. Li, P. A. Newcomb, R. E. Schoen, D. Seminara, M. L.
Slattery, J. D. Potter, E. White, U. Peters, G. Casey, L. Hsu,
T. J. Hudson.
3316
T Pathway analysis shows different leukemia
subtypes are involved with distinct biological
mechanisms.
L.-I. Hsu, F. B. Briggs, X. R. Shao, A. P.
Chokkalingam, K. M. Walsh, C. Metayer, L. F. Barcellos, P.
Buffler.
3317
F A genome-wide association study identifies new
susceptibility loci for esophageal adenocarcinoma
and Barrett’s esophagus.
D. M. Levine, W. E. Ek, R.
Fitzgerald, S. MacGregor, D. C. Whiteman, T. L. Vaughan.
3318
W Gene expression networks for non-small cell
lung cancer major subtypes.
L. Liang, M. B. Freidin,
E. Lim, A. G. Nicholson, S. Popat, M. F. Moffatt, W. O.
Cookson.
3319
T HPV and cervical cancer in Guatemala
and Venezuela-low-cost screening with NextGen
sequencing.
H. Lou, G. Villagran, U. Odey, J. Sawitzke, D.
Wells, J. Troyer, M. Dyba, A. Ruch, R. Orozco, V. Arguata,
E. Gharzouzi, E. Alvirez, M. Dean.
3320
F Individualized prostate cancer risk prediction
using a polygenic risk score.
R. Szulkin, T. Whitington, F.
Wiklund, PRACTICAL Consortium.
3321
W
BRCA1
and
BRCA2
(
BRCA) gene analyses
on an economic platform: A global consortium to
demonstrate the feasibility of a shared, dedicated
workflow for non-optical next-generation sequencing
with a custom BRCA AmpliSeq kit on the Ion Torrent
PGM™.
J. Weitzel, J. Costa, A. Mensenkamp, A. Ekici, J.
Herzog, M. Ligtenberg, H. Feilotter, P. Park, A. Hidalgo-
Miranda, N. Williams, R. Ellis, J. Carlos-Machado.
3322
T Inherited predisposition to cancer in Mexican
women.
C. M. Laukaitis, A. Chaudhury, C. Mauss, T.
Walsh, P. A. Thompson, A. M. Lopez, A. Daneri Navarro,
M.-C. King.
3323
F Association of genetic variants of cancer stem
cell genes in gallbladder cancer susceptibility in North
Indian population.
K. Sharma, B. Mittal, A. Yadav, A.
Kumar, S. Misra, V. Kumar.
3324
W Semiconductor-based next-gen sequencing
reveals cancer risk-associated genetic variations in
Chiba J-MICC cohort study.
J. Katayama, Y. Hayashi, H.
Mikami, H. Kageyama, M. Ohira, S. Yokoi, H. Nagase.
3325
T A support vector machine classifier for est ogen
receptor positive and estrogen receptor negative early-
onset breast cancer.
R. Upstill-Goddard, D. Eccles, S.
Rafiq, W. Tapper, J. Fliege, A. Collins.